Hellexsp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-10-30
Share capital
5,000.00 PLN
Registered address
ul. Zambrowska 18, 16-001 Kleosin, Poland
Electronic delivery address
AE:PL-28600-32261-DJWBA-12

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 20 days early.

  • 202501/07/2026
  • 202414/07/2025
  • 202310/07/2024
  • 202219/06/2023
  • 202105/05/2022
  • 202011/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.48mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 15.62kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 1.45mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 335.53kMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Hellex has been an NFZ healthcare provider since 2023. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmaciespodlaskie1USD 0.00

Authorized Representatives

Anna Miezio – President of the Management Board
Nikola Anna Niewiarowska – Vice President of the Management Board

Manner of representation

Each member of the management board is authorised to make declarations of will on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Anna Miezioage 51
84$1,134.5284%
Others
16$216.1016%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2014-11-04.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $12,552.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Novopharm - Millersp. j.
Pikadasp. z o.o.
Vitasp. z o.o.
Gold Lionsp. z o.o.
Grupa Aptekarska Kujałowiczsp. j.
Herbarium Świętego Franciszkasp. z o.o.
Eurekasp. z o.o.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.

Change history

DateEvent
2026-09-29PKD change
2016-04-13Address change
2015-01-23Address change
2015-01-23PKD change
2014-10-30Entered in the register

FAQ

Last updated: 2026-10-07